(Q38104737)

28 August 2017

title

The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH). (English)

1 reference

28 August 2017

0 references

prostatic hypertrophy

1 reference

8

Francesco Montorsi

1 reference

28 August 2017

2

Alberto Briganti

1 reference

28 August 2017

6

Andrea Salonia

1 reference

28 August 2017

1

Giorgio Gandaglia

1 reference

28 August 2017

3

Paolo Gontero

1 reference

28 August 2017

5

Giacomo Novara

1 reference

28 August 2017

Nicola Mondaini

4

1 reference

28 August 2017

Alessandro Sciarra

series ordinal

7

1 reference

28 August 2017

language of work or name

1 reference

12 April 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

112

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

432-441

1 reference

High prevalence of benign prostatic hypertrophy in the community

28 August 2017

cites work

1 reference

Benign prostatic hyperplasia: age-related tissue-remodeling

21 January 2018

1 reference

Serum sex hormones and measures of benign prostatic hyperplasia

21 January 2018

1 reference

Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man.

21 January 2018

1 reference

Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.

21 January 2018

1 reference

The correlation between metabolic syndrome and prostatic diseases

21 January 2018

1 reference

Metabolic syndrome and benign prostatic hyperplasia: evidence of a potential relationship, hypothesized etiology, and prevention

21 January 2018

1 reference

The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation

21 January 2018

1 reference

Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review

21 January 2018

1 reference

Intraepithelial and stromal lymphocytes in the normal human prostate

21 January 2018

1 reference

Inflammation in prostate carcinogenesis

21 January 2018

1 reference

Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.

21 January 2018

1 reference

Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue

21 January 2018

1 reference

Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?

21 January 2018

1 reference

Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis.

21 January 2018

1 reference

Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia

21 January 2018

1 reference

The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial

21 January 2018

1 reference

Do prostatic infarction, prostatic inflammation and prostate morphology play a role in acute urinary retention?

21 January 2018

1 reference

The effect of intraprostatic chronic inflammation on benign prostatic hyperplasia treatment

21 January 2018

1 reference

Lower urinary tract symptoms in benign prostatic hyperplasia patients: orchestrated by chronic prostatic inflammation and prostatic calculi?.

21 January 2018

1 reference

Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial

21 January 2018

1 reference

Human C-reactive protein and the metabolic syndrome

21 January 2018

1 reference

Inflammatory process in type 2 diabetes: The role of cytokines.

21 January 2018

1 reference

Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis

21 January 2018

1 reference

The dysregulated adipose tissue: a connecting link between insulin resistance, type 2 diabetes mellitus and atherosclerosis.

21 January 2018

1 reference

Prostatic calculi do not influence the level of serum prostate specific antigen in men without clinically detectable prostate cancer or prostatitis

21 January 2018

1 reference

EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines).

21 January 2018

1 reference

Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia

21 January 2018

1 reference

Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia

21 January 2018

1 reference

Malondialdehyde in benign prostate hypertrophy: a useful marker?

21 January 2018

1 reference

A retrospective study: correlation of histologic inflammation in biopsy specimens of Chinese men undergoing surgery for benign prostatic hyperplasia with serum prostate-specific antigen.

21 January 2018

1 reference

Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia

21 January 2018

1 reference

Anti-CTLA-4 therapy results in higher CD4+ICOShi T cell frequency and IFN-gamma levels in both nonmalignant and malignant prostate tissues

21 January 2018

1 reference

Hexanic lipidosterolic extract of Serenoa repens inhibits the expression of two key inflammatory mediators, MCP-1/CCL2 and VCAM-1, in vitro

21 January 2018

1 reference

Biomarkers for the diagnosis of prostatic inflammation in benign prostatic hyperplasia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJU.12118

1 reference

28 August 2017

1 reference